Literature DB >> 2862447

Furazolidone in peptic ulcer.

H Y Zhao, G Z Li, J D Guo, Z Yan, S W Sun, L S Li, Y M Duan, F Z Yue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2862447

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Treatment of duodenal ulceration with Furazolidine in China preceded the discovery of its association with H pylori.

Authors:  Frank-Ivor Tovey
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 2.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.

Authors:  M Tatsuta; H Ishikawa; H Iishi; S Okuda; Y Yokota
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial.

Authors:  H Humphreys; S Bourke; C Dooley; D McKenna; B Power; C T Keane; E C Sweeney; C O'Moráin
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

5.  Furazolidone, amoxicillin, bismuth and rabeprazole quadruple rescue therapy for the eradication of Helicobacter pylori.

Authors:  Hong Cheng; Fu-Lian Hu
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.